Royce & Associates LP grew its position in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 159.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 41,958 shares of the medical instruments supplier's stock after buying an additional 25,755 shares during the period. Royce & Associates LP owned approximately 1.24% of Utah Medical Products worth $2,579,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Golden State Wealth Management LLC purchased a new stake in shares of Utah Medical Products during the 4th quarter valued at about $31,000. R Squared Ltd bought a new position in Utah Medical Products during the fourth quarter valued at approximately $49,000. BNP Paribas Financial Markets boosted its holdings in Utah Medical Products by 102.7% in the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier's stock worth $75,000 after purchasing an additional 566 shares during the last quarter. SG Americas Securities LLC purchased a new stake in Utah Medical Products during the 4th quarter valued at $157,000. Finally, Virtu Financial LLC bought a new position in shares of Utah Medical Products during the 3rd quarter valued at $207,000. Institutional investors own 69.60% of the company's stock.
Utah Medical Products Price Performance
Shares of UTMD traded down $0.29 during trading hours on Tuesday, hitting $56.75. The stock had a trading volume of 12,784 shares, compared to its average volume of 20,859. The firm has a market capitalization of $192.50 million, a PE ratio of 14.37 and a beta of 0.06. Utah Medical Products, Inc. has a 12 month low of $56.67 and a 12 month high of $77.33. The stock has a fifty day moving average price of $60.17 and a 200 day moving average price of $63.08.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.
Utah Medical Products Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be given a $0.305 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.22 annualized dividend and a yield of 2.15%. Utah Medical Products's payout ratio is presently 30.89%.
Utah Medical Products Company Profile
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Read More
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
